Medical Device News Magazine

Renowned Orthopedic Surgeon, Dr. Stephen Hochschuler, Joins Backstop Neural’s Advisory Board

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Backstop Neural, a pioneering company specializing in advanced spinal cord stimulation solutions, is pleased to announce the appointment of Dr. Stephen Hochschuler to its esteemed Technical Advisory Board.

Dr. Stephen Hochschuler is a distinguished figure in the medical field, renowned for his groundbreaking work in orthopedic surgery. With over four decades of experience, Dr. Hochschuler has consistently pushed the boundaries of medical science, contributing significantly to the advancement of surgical techniques and patient care.

As a member of Backstop Neural’s Advisory Board, Dr. Hochschuler will bring his wealth of knowledge and expertise to the company’s mission of relieving pain and restoring movement. His extensive experience in the medical field, coupled with his visionary approach to healthcare, makes him an invaluable addition to the team.

“We are honored and thrilled to welcome Dr. Stephen Hochschuler to our Advisory Board,” said Connie Manz, CEO and Co-founder of Backstop Neural. “His dedication to improving the lives of patients aligns perfectly with our mission, and we believe his strategic insights and network will be instrumental in driving our neural interface technology forward.”

Dr. Hochschuler’s accomplishments include serving as co-founder of the renowned Texas Back Institute, one of the largest spine specialty clinics globally, and authoring numerous publications in esteemed medical journals. He is also a founding member of The American Board of Spine Surgery and The American College of Spin Surgery. His commitment to excellence and passion for innovation make him an ideal collaborator for Backstop Neural’s journey in creating revolutionary neural interfaces.

Backstop Neural is transforming delivery of electrical stimulation of the spinal cord for pain relief and motor recovery by leveraging novel materials and processes. Combining expertise from various fields enables the company to push the boundaries of what’s possible in the realm of neural interfaces.

Dr. Hochschuler’s appointment comes at a pivotal time for Backstop Neural as the company continues to make significant strides in its product development efforts. His contributions to the Technical Advisory Board will undoubtedly play a crucial role in shaping the future of spinal cord stimulation for pain and motor recovery.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”